The Southern Company JR 2017B NT 77 (SOJC) Balance Sheet

The sequential increase in PPE net from $115.7B in 2025Q4 to $119.2B in 2026Q2, coupled with capex averaging $2.6B per quarter, suggests the company is in a heavy construction cycle. This asset growth, however, has not yet translated into proportional equity growth, as equity rose only from $36.0B to $42.3B over the same period, implying significant debt financing of the expansion. Investors should monitor whether regulatory approvals keep pace with this capital deployment to avoid earning on unapproved assets.

The gap between capex and depreciation—capex averaging $2.6B per quarter versus depreciation of $1.4B—suggests that the company is investing heavily in new assets that will enter rate base. However, the regulatory recovery timeline lag means that these investments may not immediately contribute to earnings, as evidenced by the modest ROE of 2.9% in 2026Q2. This lag is a key risk, as delayed rate case outcomes could compress returns despite asset growth.

The D/E ratio of 1.71 in 2026Q2, though down from 1.90 in 2026Q1, remains elevated relative to peers like NEE (1.44) and DUK (1.71), indicating a higher reliance on debt. With equity growing only $8.4B over the past year versus debt growth of $7.2B, the company appears to be funding its capex program with a mix that may strain regulatory capital structure parameters. If leverage exceeds authorized levels, the company may face challenges in rate case filings, potentially leading to disallowed costs or lower allowed returns.

The equity-to-assets ratio has remained stable at 0.25-0.26 over the past ten quarters, indicating that the company is maintaining a consistent capital structure. However, the ROE of 2.9% in 2026Q2 is well below the typical authorized ROE of 9-10%, suggesting that the company is not yet earning its allowed return on equity. This may indicate that the equity growth is not fully supported by retained earnings, and investors should monitor the sustainability of dividend payouts if ROE remains suppressed.

The current ratio of 0.63 is below the peer average of approximately 0.66, suggesting that the company may face short-term liquidity constraints. However, the company has demonstrated access to capital markets, as evidenced by the $1.0B long-term debt issuance in 2026Q1, which may alleviate immediate concerns. The stable cash balance of $981M, despite heavy capex, suggests that the company is relying on external financing to bridge the gap, which could increase interest costs and pressure future earnings.

The significant investment in rate base, coupled with the regulatory lag observed in the income statement (operating margin fell to 13.1% in 2025Q4), suggests that the company is not yet earning on its new assets. The company's reliance on tracker and rider mechanisms, as typical for utilities, may provide some protection, but the pace of rate case filings will be critical. Investors should monitor the regulatory calendar and any signs of disallowances, which could impair the recovery of these investments.